914 related articles for article (PubMed ID: 24016463)
1. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
Chételat G; Fouquet M
Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
[TBL] [Abstract][Full Text] [Related]
2. Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.
Fouquet M; Besson FL; Gonneaud J; La Joie R; Chételat G
Neuropsychol Rev; 2014 Sep; 24(3):290-9. PubMed ID: 25146994
[TBL] [Abstract][Full Text] [Related]
3. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
Sampedro F; Vilaplana E; de Leon MJ; Alcolea D; Pegueroles J; Montal V; Carmona-Iragui M; Sala I; Sánchez-Saudinos MB; Antón-Aguirre S; Morenas-Rodríguez E; Camacho V; Falcón C; Pavía J; Ros D; Clarimón J; Blesa R; Lleó A; Fortea J;
Oncotarget; 2015 Sep; 6(29):26663-74. PubMed ID: 26397226
[TBL] [Abstract][Full Text] [Related]
4. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G
J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136
[TBL] [Abstract][Full Text] [Related]
5. Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention.
Vanitallie TB
Metabolism; 2013 Jan; 62 Suppl 1():S30-3. PubMed ID: 23021038
[TBL] [Abstract][Full Text] [Related]
6. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
[TBL] [Abstract][Full Text] [Related]
7. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
Blautzik J; Kotz S; Brendel M; Sauerbeck J; Vettermann F; Winter Y; Bartenstein P; Ishii K; Rominger A;
J Alzheimers Dis; 2018; 65(3):781-791. PubMed ID: 28697560
[TBL] [Abstract][Full Text] [Related]
8. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
Huang Y
Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
[TBL] [Abstract][Full Text] [Related]
9. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
10. Vascular Dysfunction Is Central to Alzheimer's Disease Pathogenesis in APOE e4 Carriers.
McCorkindale AN; Mundell HD; Guennewig B; Sutherland GT
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806110
[TBL] [Abstract][Full Text] [Related]
11. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
12. Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype.
Gispert JD; Rami L; Sánchez-Benavides G; Falcon C; Tucholka A; Rojas S; Molinuevo JL
Neurobiol Aging; 2015 Oct; 36(10):2687-701. PubMed ID: 26239178
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
[TBL] [Abstract][Full Text] [Related]
14. Impact of Apolipoprotein E4 on the Locus Coeruleus Functional Connectivity in Preclinical Alzheimer's Disease.
Um YH; Wang SM; Kang DW; Kim S; Lee CU; Kim D; Choe YS; Kim REY; Lee S; Lee MK; Lim HK
J Alzheimers Dis; 2024; 99(2):705-714. PubMed ID: 38669549
[TBL] [Abstract][Full Text] [Related]
15. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
Pardo JV; Lee JT;
eNeuro; 2018; 5(1):. PubMed ID: 29497704
[TBL] [Abstract][Full Text] [Related]
16. APOE effects on regional tau in preclinical Alzheimer's disease.
Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
[TBL] [Abstract][Full Text] [Related]
17. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network.
Bussy A; Snider BJ; Coble D; Xiong C; Fagan AM; Cruchaga C; Benzinger TLS; Gordon BA; Hassenstab J; Bateman RJ; Morris JC;
Neurobiol Aging; 2019 Mar; 75():42-50. PubMed ID: 30530186
[TBL] [Abstract][Full Text] [Related]
18. Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer's Disease Trajectory?
Femminella GD; Taylor-Davies G; Scott J; Edison P;
J Alzheimers Dis; 2018; 64(3):981-993. PubMed ID: 29966204
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
[TBL] [Abstract][Full Text] [Related]
20. ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.
Steward A; Biel D; Dewenter A; Roemer S; Wagner F; Dehsarvi A; Rathore S; Otero Svaldi D; Higgins I; Brendel M; Dichgans M; Shcherbinin S; Ewers M; Franzmeier N
JAMA Neurol; 2023 Dec; 80(12):1295-1306. PubMed ID: 37930695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
